News

Ayudas Externas

27 - ene. - 2020
The IMI-2 Call for Innovative Medicines Initiative (IMI-2) is open

The call gives researchers from various sectors the opportunity to participate in ambitious public-private partnerships for the development of future medicines.

IMI2 - Call 20 was launched on January 21, 2020 and is a call for standard two-stage proposals.

Why request?

- Obtain funds for research.

- Participate in a scientifically excellent patient-centered investigation

- Join unique consortia that involve the best teams in the industry, academia, SMEs, regulators and others.

- It means benefiting from the experience, databases and infrastructure of the consortium partners.

- Increase the visibility and status of your organization in Europe and worldwide and access to new markets.

Themes

- Early diagnosis, prediction of radiographic results and development of rational and personalized treatment strategies to improve long-term results in psoriatic arthritis.

- Innovations to accelerate the development and manufacture of vaccines.

- Academy merger in innovation and treatment for tuberculosis (UNITE4TB).

- Tumor plasticity.

- Proton versus photon therapy for esophageal cancer - trimodality strategy.

- Management of protein pharmacological products and stability problems.

More information on the topics: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-20

Deadline for short proposals: April 21, 2020

CONTACT

Visit the IMI website: www.imi.europa.eu

For more information about the call you can contact projects1@idival.org

 

Gobierno de Cantabria  Servicio Cántabro de Salud  Hospital Universitario Marqués de Valdecilla   Universidad de Cantabria     

INSTITUTO DE INVESTIGACIÓN MARQUÉS DE VALDECILLA
Edificio IDIVAL, Avenida Cardenal Herrera Oria s/n,
39011 Santander (CANTABRIA).

Phone.: 942 31 55 15
Fax: 942 31 55 17

  

  • LINKS


EVENTS
events

Copyright 2022 IDIVAL Terms | Privacy | Cookies law